Bristol-Myers Squibb has received a Food and Drugs Agency (FDA) complete response letter about the b
Drug's first-quarter sales up nearly a third on the same period last year, generating $154 million.
Swine flu vaccine helps boost pharmaceutical and healthcare company’s profits by 16 per cent in Q1.
Company to pay $520m.
Russian operator hopes to simplify its overall network operations model.
The software will enhance quality in conjunction with virtual autopsies.
Company reaches agreement with not-for-profit Medicines for Malaria Venture (MMV)
Biotech firm reports revenues of EUR61.68m for the full year ended December 31, 2009,
New initiative to address safety problems associated with external infusion pumps.
Co-promotion agreement for new drug
Biotage to acquire shares for 16m Swedish Kronor
The health care company made the acquisition to strengthen its presence in immunology and oncology.
The company has achieved a milestone under its collaboration agreement with Bayer Schering Pharma.
However earnings of the pharmaceuticals company were hit by US healthcare reform.
$9.5m deal will see Genentech responsible for research.
Alexander Wessels to become president and CEO of DSM Pharmaceutical Products.
The healthcare firm's first quarter sales are up CHF12.2bn (Swiss Francs).
The company is to acquire the provider of data management solutions for $17 per share in cash.
Peter Downing has been selected as North East Territory Manager for Ultrasound.
Stemgent will make reagents discovered or developed by Pfizer available to the global research commu
Robert Dougall, a former director of marketing at a Johnson & Johnson subsidiary, has been jailed fo
The pharmaceutical companies have agreed to identify and select up to five compounds for generic dev
Pharmaceutical firm gets marketing authorisation for Ribavirin 200mg film-coated tablets
Sanofi-aventis and CureDM have entered into a global licence agreement on a new human peptide which
The investor has pumped funds into the pharmaceutical company for a generic drug manufacturing facil
Research collaboration will develop individualised cancer treatment decisions.
The company has entered into an exclusive partnership with Therabel group, landing it €48.5m.
Companies come together to create therapeutics for the treatment of autoimmune and inflammatory diso
AtCor Medical, a developer and marketer of the SphygmoCor system has signed a $955,000 agreement wit
Eli Lilly and Company has received a positive Final Appraisal Determination (FAD) for chemotherapy A